Background and Objectives: Lung cancer (LC) remains a significant global health issue with poor prognosis. The COVID-19 pandemic has caused delays in cancer patient management worldwide. However, its impact on the incidence of LCs in Romania has not yet been discussed. We aimed to evaluate the impact of lockdown restrictions during the COVID-19 pandemic on new LC diagnoses in a Romanian cohort and the potential associations between demographic characteristics and histological features. Materials and Methods: This retrospective study analyzed 750 patients with lung tumors diagnosed in the Pathology Department, Mureș County Clinical Hospital, Romania, between 2018 and 2022. The target population was divided in two cohorts: pre-COVID-19 (1 January 2018–15 March 2020) and COVID-19 (16 March 2020–31 December 2022). Results: The temporal trend of LC diagnosis followed a descending pattern over the study period, with a significant 72% reduction (p < 0.001) in the first year of the COVID-19 pandemic (2020 vs. 2019). In terms of histology, several subtypes displayed a notable reduction in the COVID-19 cohort compared to the pre-pandemic period: squamous carcinoma (SQC) (p < 0.001), adenocarcinoma (ADK) (p < 0.001), and lung metastases (p = 0.0008). On the other hand, cases of non-small-cell lung carcinomas not otherwise specified (NSCLCs NOS) experienced a significant increase in the pandemic years (p = 0.0406). SQC was the most frequent subtype of LC and was significantly more frequent in men (p < 0.001, RR = 1.3004, 95% CI [1.1786–1.4347]). Furthermore, a notable shift in the male-to-female ratio was observed between the two cohorts, caused by a larger decrease in the incidence of LC among men compared to females in the COVID-19 period (p = 0.0002; pre-COVID-19 M/F = 4/1 versus COVID-19 M/F = 2/1). Conclusions: COVID-19-related restrictions led to a significant drop in new LC diagnoses during the first year of the pandemic, which was followed by a slight upward trend in the subsequent years. Additionally, the sharp decline in the number of cases among men narrowed the gender gap in LC patients.
Background/Objectives: In this study, we aimed to assess the impact of the COVID-19 (Coronavirus Disease 2019) pandemic period on the time trend prevalence of thyroid pathology in a university hospital in Romania. Methods: We performed a 6-year retrospective study (2017–2022) including all patients who underwent thyroid surgery, registered in the Pathology Department, Emergency County Hospital, Târgu-Mureș, Romania (n = 971). Thyroid lesions were grouped into three major categories: (1) benign, non-tumoral; (2) benign, tumoral; and (3) malignant, tumoral. To assess the impact of the COVID-19 pandemic on the annual rate of thyroid surgeries and thyroid pathology, data were analyzed in comparison: before COVID-19 (2017–2019) versus the COVID-19 (2020–2022) period. Results: A significant decrease in the mean number of thyroid specimens per year was observed in the COVID-19 period compared to the previous period (131 versus 192 cases, p = 0.0023). Thyroid benign lesions were the most frequent, but their prevalence was significantly lower during the pandemic period (50.8%) compared to the previous period (58.6%) (p = 0.017). Benign tumors were rare, revealing similar occurrence rates in both periods. By contrast, the annual rate of malignant tumors increased significantly during the COVID-19 period (26.3% versus 35.4%, p = 0.002), the most common histopathological type being papillary thyroid carcinoma. Conclusions: Along with the COVID-19 pandemic (starting in the year 2020), due to reduced access to medical investigations, many thyroid cancers remained unoperated in our hospital. Consequently, this has led to an increased prevalence of malignant cases in the years that came after.
Background/Objectives: In the present study, we aimed to analyze the temporal trends in the prevalence of adrenal tumors diagnosed over a 22 years’ period (2001-2022) in a university hospital in Romania. Additionally, our goal was to highlight and illustrate the demographic and histo-pathological features of these rare tumors within our population. Methods: We performed a retrospective review of 116 cases of adrenal lesions registered in our institution. Data was analyzed in a comparative way, by dividing the study period into two equal 11 years’ time-intervals: 2001-2011 vs. 2012-2022. Results: Within our study population, the most common lesions were adenomas (31.9%), followed by pheochromocytomas (24.1%), and adrenal cortical carcinomas (11.2%); other lesions (eg. cysts, myeloliopma, etc.) were rare. Adrenal surgeries increased by 36% in the last 11 years (n=49 cases in 2001-2011 vs. n=67 cases in 2012-2022, p=0.095). The prevalence of adrenal adenomas almost doubled in the second study period (38.8% vs. 22.4%, p=0.014). Pheochromocytomas remained constant, revealing a similar prevalence (around 24%) in both time periods. Carcinomas’ prevalence was lower in 2012-2022 compared to 2001-2011 (7.4% vs. 16.3%, p=0.405). Conclusion: Our study demonstrated an increased prevalence of adrenal tumors in our institution over the last 11 years (2011-2022) compared to the previous period (2001- 2011). Adrenal cortical adenomas were the most common tumors, with a prevalence that was almost double between 2011-2022 vs. 2001-2011. They were followed by pheochromocytomas, which showed a constant prevalence, and by cortical carcinomas whose prevalence has decreased over the past decade in our institution.
Background/Objectives: In this study we aimed to assess the impact of Covid-19 pandemic period on the epidemiological trend of thyroid pathology in a university hospital in Romania. Methods: We performed a 6-years retrospective study (2017-2022) including all patients who underwent thyroid surgery, registered in the Pathology Department, Emergency County Hospital, Târgu-Mureș, Romania (n=971). Thyroid lesions were grouped into 3 major categories: (1) benign, non-tumoral, (2) benign, tumoral and (3) malignant, tumoral. To assess the impact of Covid-19 pandemic on the annual rate of thyroid surgeries and thyroid pathology, data were analyzed in comparison: before Covid-19 (2017-2019) versus Covid-19 and post-Covid-19 (2020-2022) period. Results: A significant decrease in the mean number of thyroid specimens per year was observed in the Covid-19 and post-Covid-19 period, compared to the previous period (131 versus 192 cases, p=0.0023). Thyroid benign lesions were the most frequent, but their prevalence was significantly lower during the pandemic period (50.8%), compared to the previous period (58.6%) (p=0.017). Benign tumors were rare, revealing similar occurrence rates in both periods. By contrast, the annual rate of malignant tumors increased significantly during Covid-19 and post-Covid-19 period (26.3% versus 35.4%, p=0.002), the most common histopathological type being papillary thyroid carcinoma. Conclusion: Along with Covid-19 pandemic (year 2020), due to reduced access to medical investigations, many thyroid cancers remained undiagnosed in our hospital. Consequently, this has led to an increased prevalence of malignant cases in the years that came after.